nodes	percent_of_prediction	percent_of_DWPC	metapath
Irinotecan—ALB—Auranofin—psoriatic arthritis	0.126	0.155	CbGbCtD
Irinotecan—BCHE—Triamcinolone—psoriatic arthritis	0.103	0.127	CbGbCtD
Irinotecan—ABCC1—Methotrexate—psoriatic arthritis	0.0435	0.0535	CbGbCtD
Irinotecan—ABCC2—Dexamethasone—psoriatic arthritis	0.0401	0.0493	CbGbCtD
Irinotecan—ALB—Prednisone—psoriatic arthritis	0.04	0.0492	CbGbCtD
Irinotecan—SLCO1B1—Methotrexate—psoriatic arthritis	0.0367	0.0451	CbGbCtD
Irinotecan—ABCG2—Dexamethasone—psoriatic arthritis	0.0362	0.0446	CbGbCtD
Irinotecan—ABCB1—Methylprednisolone—psoriatic arthritis	0.0346	0.0425	CbGbCtD
Irinotecan—ABCC2—Methotrexate—psoriatic arthritis	0.0322	0.0396	CbGbCtD
Irinotecan—ABCG2—Methotrexate—psoriatic arthritis	0.0291	0.0358	CbGbCtD
Irinotecan—CYP3A7—Dexamethasone—psoriatic arthritis	0.0268	0.0329	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Dexamethasone—psoriatic arthritis	0.0268	0.0329	CbGbCtD
Irinotecan—CYP2B6—Dexamethasone—psoriatic arthritis	0.0255	0.0313	CbGbCtD
Irinotecan—ABCB1—Betamethasone—psoriatic arthritis	0.0225	0.0276	CbGbCtD
Irinotecan—ABCB1—Prednisolone—psoriatic arthritis	0.0222	0.0273	CbGbCtD
Irinotecan—ABCB1—Prednisone—psoriatic arthritis	0.0209	0.0257	CbGbCtD
Irinotecan—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0207	0.0255	CbGbCtD
Irinotecan—CYP3A5—Dexamethasone—psoriatic arthritis	0.0201	0.0247	CbGbCtD
Irinotecan—ALB—Methotrexate—psoriatic arthritis	0.0201	0.0247	CbGbCtD
Irinotecan—CYP3A4—Triamcinolone—psoriatic arthritis	0.0157	0.0193	CbGbCtD
Irinotecan—CYP3A4—Betamethasone—psoriatic arthritis	0.0135	0.0166	CbGbCtD
Irinotecan—CYP3A4—Prednisolone—psoriatic arthritis	0.0133	0.0163	CbGbCtD
Irinotecan—ABCB1—Dexamethasone—psoriatic arthritis	0.0131	0.0161	CbGbCtD
Irinotecan—CYP3A4—Prednisone—psoriatic arthritis	0.0125	0.0154	CbGbCtD
Irinotecan—ABCB1—Methotrexate—psoriatic arthritis	0.0105	0.0129	CbGbCtD
Irinotecan—CYP3A4—Dexamethasone—psoriatic arthritis	0.00783	0.00963	CbGbCtD
Irinotecan—Back pain—Triamcinolone—psoriatic arthritis	0.000307	0.00164	CcSEcCtD
Irinotecan—Loss of consciousness—Prednisolone—psoriatic arthritis	0.000303	0.00162	CcSEcCtD
Irinotecan—Angiopathy—Betamethasone—psoriatic arthritis	0.0003	0.00161	CcSEcCtD
Irinotecan—Angiopathy—Dexamethasone—psoriatic arthritis	0.0003	0.00161	CcSEcCtD
Irinotecan—Hypertension—Prednisolone—psoriatic arthritis	0.000298	0.00159	CcSEcCtD
Irinotecan—Arrhythmia—Dexamethasone—psoriatic arthritis	0.000295	0.00158	CcSEcCtD
Irinotecan—Arrhythmia—Betamethasone—psoriatic arthritis	0.000295	0.00158	CcSEcCtD
Irinotecan—Pancreatitis—Methotrexate—psoriatic arthritis	0.000295	0.00158	CcSEcCtD
Irinotecan—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.000294	0.00157	CcSEcCtD
Irinotecan—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.000293	0.00157	CcSEcCtD
Irinotecan—Bradycardia—Prednisone—psoriatic arthritis	0.000293	0.00157	CcSEcCtD
Irinotecan—Alopecia—Dexamethasone—psoriatic arthritis	0.000292	0.00156	CcSEcCtD
Irinotecan—Alopecia—Betamethasone—psoriatic arthritis	0.000292	0.00156	CcSEcCtD
Irinotecan—Discomfort—Prednisolone—psoriatic arthritis	0.00029	0.00155	CcSEcCtD
Irinotecan—Haemoglobin—Prednisone—psoriatic arthritis	0.000289	0.00155	CcSEcCtD
Irinotecan—Haemorrhage—Prednisone—psoriatic arthritis	0.000288	0.00154	CcSEcCtD
Irinotecan—Malaise—Triamcinolone—psoriatic arthritis	0.000286	0.00153	CcSEcCtD
Irinotecan—Malaise—Methylprednisolone—psoriatic arthritis	0.000285	0.00153	CcSEcCtD
Irinotecan—Vertigo—Triamcinolone—psoriatic arthritis	0.000285	0.00152	CcSEcCtD
Irinotecan—Syncope—Triamcinolone—psoriatic arthritis	0.000284	0.00152	CcSEcCtD
Irinotecan—Vertigo—Methylprednisolone—psoriatic arthritis	0.000284	0.00152	CcSEcCtD
Irinotecan—Syncope—Methylprednisolone—psoriatic arthritis	0.000284	0.00152	CcSEcCtD
Irinotecan—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000283	0.00151	CcSEcCtD
Irinotecan—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000281	0.00151	CcSEcCtD
Irinotecan—Oedema—Prednisolone—psoriatic arthritis	0.000281	0.00151	CcSEcCtD
Irinotecan—Neutropenia—Methotrexate—psoriatic arthritis	0.000281	0.0015	CcSEcCtD
Irinotecan—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.000279	0.0015	CcSEcCtD
Irinotecan—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000279	0.00149	CcSEcCtD
Irinotecan—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000278	0.00149	CcSEcCtD
Irinotecan—Shock—Prednisolone—psoriatic arthritis	0.000277	0.00148	CcSEcCtD
Irinotecan—Cough—Triamcinolone—psoriatic arthritis	0.000277	0.00148	CcSEcCtD
Irinotecan—Hypertension—Triamcinolone—psoriatic arthritis	0.000274	0.00147	CcSEcCtD
Irinotecan—Hypertension—Methylprednisolone—psoriatic arthritis	0.000273	0.00146	CcSEcCtD
Irinotecan—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000272	0.00146	CcSEcCtD
Irinotecan—Pneumonia—Methotrexate—psoriatic arthritis	0.000269	0.00144	CcSEcCtD
Irinotecan—Flushing—Prednisone—psoriatic arthritis	0.000267	0.00143	CcSEcCtD
Irinotecan—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000267	0.00143	CcSEcCtD
Irinotecan—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000267	0.00143	CcSEcCtD
Irinotecan—Discomfort—Triamcinolone—psoriatic arthritis	0.000267	0.00143	CcSEcCtD
Irinotecan—Discomfort—Methylprednisolone—psoriatic arthritis	0.000266	0.00142	CcSEcCtD
Irinotecan—Renal failure—Methotrexate—psoriatic arthritis	0.000263	0.00141	CcSEcCtD
Irinotecan—Stomatitis—Methotrexate—psoriatic arthritis	0.000261	0.0014	CcSEcCtD
Irinotecan—Angiopathy—Prednisone—psoriatic arthritis	0.000261	0.0014	CcSEcCtD
Irinotecan—Confusional state—Methylprednisolone—psoriatic arthritis	0.00026	0.00139	CcSEcCtD
Irinotecan—Immune system disorder—Prednisone—psoriatic arthritis	0.00026	0.00139	CcSEcCtD
Irinotecan—Malaise—Dexamethasone—psoriatic arthritis	0.000259	0.00139	CcSEcCtD
Irinotecan—Malaise—Betamethasone—psoriatic arthritis	0.000259	0.00139	CcSEcCtD
Irinotecan—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000259	0.00139	CcSEcCtD
Irinotecan—Oedema—Triamcinolone—psoriatic arthritis	0.000259	0.00139	CcSEcCtD
Irinotecan—Vertigo—Dexamethasone—psoriatic arthritis	0.000258	0.00138	CcSEcCtD
Irinotecan—Vertigo—Betamethasone—psoriatic arthritis	0.000258	0.00138	CcSEcCtD
Irinotecan—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000258	0.00138	CcSEcCtD
Irinotecan—Syncope—Dexamethasone—psoriatic arthritis	0.000258	0.00138	CcSEcCtD
Irinotecan—Syncope—Betamethasone—psoriatic arthritis	0.000258	0.00138	CcSEcCtD
Irinotecan—Arrhythmia—Prednisone—psoriatic arthritis	0.000257	0.00138	CcSEcCtD
Irinotecan—Infection—Triamcinolone—psoriatic arthritis	0.000257	0.00138	CcSEcCtD
Irinotecan—Sweating—Methotrexate—psoriatic arthritis	0.000257	0.00138	CcSEcCtD
Irinotecan—Infection—Methylprednisolone—psoriatic arthritis	0.000256	0.00137	CcSEcCtD
Irinotecan—Shock—Triamcinolone—psoriatic arthritis	0.000255	0.00136	CcSEcCtD
Irinotecan—Insomnia—Prednisolone—psoriatic arthritis	0.000254	0.00136	CcSEcCtD
Irinotecan—Alopecia—Prednisone—psoriatic arthritis	0.000254	0.00136	CcSEcCtD
Irinotecan—Shock—Methylprednisolone—psoriatic arthritis	0.000254	0.00136	CcSEcCtD
Irinotecan—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000253	0.00136	CcSEcCtD
Irinotecan—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000253	0.00135	CcSEcCtD
Irinotecan—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000253	0.00135	CcSEcCtD
Irinotecan—Paraesthesia—Prednisolone—psoriatic arthritis	0.000253	0.00135	CcSEcCtD
Irinotecan—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00025	0.00134	CcSEcCtD
Irinotecan—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00025	0.00134	CcSEcCtD
Irinotecan—Hypertension—Betamethasone—psoriatic arthritis	0.000248	0.00133	CcSEcCtD
Irinotecan—Hypertension—Dexamethasone—psoriatic arthritis	0.000248	0.00133	CcSEcCtD
Irinotecan—Discomfort—Betamethasone—psoriatic arthritis	0.000242	0.0013	CcSEcCtD
Irinotecan—Discomfort—Dexamethasone—psoriatic arthritis	0.000242	0.0013	CcSEcCtD
Irinotecan—Haemoglobin—Methotrexate—psoriatic arthritis	0.000242	0.00129	CcSEcCtD
Irinotecan—Hypotension—Methylprednisolone—psoriatic arthritis	0.000241	0.00129	CcSEcCtD
Irinotecan—Pain—Prednisolone—psoriatic arthritis	0.000241	0.00129	CcSEcCtD
Irinotecan—Haemorrhage—Methotrexate—psoriatic arthritis	0.00024	0.00129	CcSEcCtD
Irinotecan—Oedema—Dexamethasone—psoriatic arthritis	0.000235	0.00126	CcSEcCtD
Irinotecan—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000235	0.00126	CcSEcCtD
Irinotecan—Oedema—Betamethasone—psoriatic arthritis	0.000235	0.00126	CcSEcCtD
Irinotecan—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000235	0.00126	CcSEcCtD
Irinotecan—Insomnia—Triamcinolone—psoriatic arthritis	0.000234	0.00125	CcSEcCtD
Irinotecan—Insomnia—Methylprednisolone—psoriatic arthritis	0.000233	0.00125	CcSEcCtD
Irinotecan—Infection—Dexamethasone—psoriatic arthritis	0.000233	0.00125	CcSEcCtD
Irinotecan—Infection—Betamethasone—psoriatic arthritis	0.000233	0.00125	CcSEcCtD
Irinotecan—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000232	0.00124	CcSEcCtD
Irinotecan—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000232	0.00124	CcSEcCtD
Irinotecan—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000232	0.00124	CcSEcCtD
Irinotecan—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000232	0.00124	CcSEcCtD
Irinotecan—Visual impairment—Methotrexate—psoriatic arthritis	0.000232	0.00124	CcSEcCtD
Irinotecan—Anaemia—Prednisone—psoriatic arthritis	0.000232	0.00124	CcSEcCtD
Irinotecan—Shock—Betamethasone—psoriatic arthritis	0.000231	0.00124	CcSEcCtD
Irinotecan—Shock—Dexamethasone—psoriatic arthritis	0.000231	0.00124	CcSEcCtD
Irinotecan—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000231	0.00123	CcSEcCtD
Irinotecan—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00023	0.00123	CcSEcCtD
Irinotecan—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00023	0.00123	CcSEcCtD
Irinotecan—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00023	0.00123	CcSEcCtD
Irinotecan—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00023	0.00123	CcSEcCtD
Irinotecan—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000228	0.00122	CcSEcCtD
Irinotecan—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000227	0.00122	CcSEcCtD
Irinotecan—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000227	0.00122	CcSEcCtD
Irinotecan—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000227	0.00122	CcSEcCtD
Irinotecan—Malaise—Prednisone—psoriatic arthritis	0.000226	0.00121	CcSEcCtD
Irinotecan—Vertigo—Prednisone—psoriatic arthritis	0.000225	0.0012	CcSEcCtD
Irinotecan—Syncope—Prednisone—psoriatic arthritis	0.000225	0.0012	CcSEcCtD
Irinotecan—Anorexia—Dexamethasone—psoriatic arthritis	0.000224	0.0012	CcSEcCtD
Irinotecan—Anorexia—Betamethasone—psoriatic arthritis	0.000224	0.0012	CcSEcCtD
Irinotecan—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000223	0.00119	CcSEcCtD
Irinotecan—Fatigue—Triamcinolone—psoriatic arthritis	0.000223	0.00119	CcSEcCtD
Irinotecan—Fatigue—Methylprednisolone—psoriatic arthritis	0.000223	0.00119	CcSEcCtD
Irinotecan—Pain—Triamcinolone—psoriatic arthritis	0.000221	0.00118	CcSEcCtD
Irinotecan—Loss of consciousness—Prednisone—psoriatic arthritis	0.00022	0.00118	CcSEcCtD
Irinotecan—Hypotension—Dexamethasone—psoriatic arthritis	0.000219	0.00117	CcSEcCtD
Irinotecan—Hypotension—Betamethasone—psoriatic arthritis	0.000219	0.00117	CcSEcCtD
Irinotecan—Angiopathy—Methotrexate—psoriatic arthritis	0.000218	0.00117	CcSEcCtD
Irinotecan—Immune system disorder—Methotrexate—psoriatic arthritis	0.000217	0.00116	CcSEcCtD
Irinotecan—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000217	0.00116	CcSEcCtD
Irinotecan—Hypertension—Prednisone—psoriatic arthritis	0.000216	0.00116	CcSEcCtD
Irinotecan—Chills—Methotrexate—psoriatic arthritis	0.000216	0.00116	CcSEcCtD
Irinotecan—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000213	0.00114	CcSEcCtD
Irinotecan—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000213	0.00114	CcSEcCtD
Irinotecan—Alopecia—Methotrexate—psoriatic arthritis	0.000213	0.00114	CcSEcCtD
Irinotecan—Insomnia—Dexamethasone—psoriatic arthritis	0.000212	0.00114	CcSEcCtD
Irinotecan—Insomnia—Betamethasone—psoriatic arthritis	0.000212	0.00114	CcSEcCtD
Irinotecan—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000211	0.00113	CcSEcCtD
Irinotecan—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000211	0.00113	CcSEcCtD
Irinotecan—Paraesthesia—Betamethasone—psoriatic arthritis	0.000211	0.00113	CcSEcCtD
Irinotecan—Discomfort—Prednisone—psoriatic arthritis	0.000211	0.00113	CcSEcCtD
Irinotecan—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000207	0.00111	CcSEcCtD
Irinotecan—Dyspepsia—Betamethasone—psoriatic arthritis	0.000207	0.00111	CcSEcCtD
Irinotecan—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000207	0.00111	CcSEcCtD
Irinotecan—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000205	0.0011	CcSEcCtD
Irinotecan—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000204	0.00109	CcSEcCtD
Irinotecan—Oedema—Prednisone—psoriatic arthritis	0.000204	0.00109	CcSEcCtD
Irinotecan—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000204	0.00109	CcSEcCtD
Irinotecan—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000204	0.00109	CcSEcCtD
Irinotecan—Decreased appetite—Betamethasone—psoriatic arthritis	0.000204	0.00109	CcSEcCtD
Irinotecan—Infection—Prednisone—psoriatic arthritis	0.000203	0.00109	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000203	0.00109	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000203	0.00109	CcSEcCtD
Irinotecan—Back pain—Methotrexate—psoriatic arthritis	0.000202	0.00108	CcSEcCtD
Irinotecan—Fatigue—Betamethasone—psoriatic arthritis	0.000202	0.00108	CcSEcCtD
Irinotecan—Fatigue—Dexamethasone—psoriatic arthritis	0.000202	0.00108	CcSEcCtD
Irinotecan—Shock—Prednisone—psoriatic arthritis	0.000201	0.00108	CcSEcCtD
Irinotecan—Pain—Betamethasone—psoriatic arthritis	0.000201	0.00107	CcSEcCtD
Irinotecan—Pain—Dexamethasone—psoriatic arthritis	0.000201	0.00107	CcSEcCtD
Irinotecan—Nervous system disorder—Prednisone—psoriatic arthritis	0.0002	0.00107	CcSEcCtD
Irinotecan—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000198	0.00106	CcSEcCtD
Irinotecan—Anorexia—Prednisone—psoriatic arthritis	0.000195	0.00104	CcSEcCtD
Irinotecan—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000194	0.00104	CcSEcCtD
Irinotecan—Anaemia—Methotrexate—psoriatic arthritis	0.000193	0.00104	CcSEcCtD
Irinotecan—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000193	0.00104	CcSEcCtD
Irinotecan—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000193	0.00104	CcSEcCtD
Irinotecan—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000192	0.00103	CcSEcCtD
Irinotecan—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000192	0.00103	CcSEcCtD
Irinotecan—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000191	0.00102	CcSEcCtD
Irinotecan—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00019	0.00102	CcSEcCtD
Irinotecan—Malaise—Methotrexate—psoriatic arthritis	0.000189	0.00101	CcSEcCtD
Irinotecan—Vertigo—Methotrexate—psoriatic arthritis	0.000188	0.00101	CcSEcCtD
Irinotecan—Leukopenia—Methotrexate—psoriatic arthritis	0.000187	0.001	CcSEcCtD
Irinotecan—Dizziness—Prednisolone—psoriatic arthritis	0.000186	0.000996	CcSEcCtD
Irinotecan—Asthenia—Triamcinolone—psoriatic arthritis	0.000186	0.000994	CcSEcCtD
Irinotecan—Body temperature increased—Betamethasone—psoriatic arthritis	0.000186	0.000994	CcSEcCtD
Irinotecan—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000186	0.000994	CcSEcCtD
Irinotecan—Abdominal pain—Betamethasone—psoriatic arthritis	0.000186	0.000994	CcSEcCtD
Irinotecan—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000186	0.000994	CcSEcCtD
Irinotecan—Asthenia—Methylprednisolone—psoriatic arthritis	0.000185	0.000992	CcSEcCtD
Irinotecan—Insomnia—Prednisone—psoriatic arthritis	0.000185	0.00099	CcSEcCtD
Irinotecan—Paraesthesia—Prednisone—psoriatic arthritis	0.000184	0.000983	CcSEcCtD
Irinotecan—Cough—Methotrexate—psoriatic arthritis	0.000183	0.000978	CcSEcCtD
Irinotecan—Dyspepsia—Prednisone—psoriatic arthritis	0.00018	0.000963	CcSEcCtD
Irinotecan—Decreased appetite—Prednisone—psoriatic arthritis	0.000178	0.000951	CcSEcCtD
Irinotecan—Rash—Prednisolone—psoriatic arthritis	0.000177	0.00095	CcSEcCtD
Irinotecan—Dermatitis—Prednisolone—psoriatic arthritis	0.000177	0.000949	CcSEcCtD
Irinotecan—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000177	0.000946	CcSEcCtD
Irinotecan—Fatigue—Prednisone—psoriatic arthritis	0.000176	0.000944	CcSEcCtD
Irinotecan—Headache—Prednisolone—psoriatic arthritis	0.000176	0.000944	CcSEcCtD
Irinotecan—Discomfort—Methotrexate—psoriatic arthritis	0.000176	0.000943	CcSEcCtD
Irinotecan—Constipation—Prednisone—psoriatic arthritis	0.000175	0.000936	CcSEcCtD
Irinotecan—Confusional state—Methotrexate—psoriatic arthritis	0.000172	0.000922	CcSEcCtD
Irinotecan—Dizziness—Triamcinolone—psoriatic arthritis	0.000171	0.000916	CcSEcCtD
Irinotecan—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000171	0.000915	CcSEcCtD
Irinotecan—Dizziness—Methylprednisolone—psoriatic arthritis	0.000171	0.000914	CcSEcCtD
Irinotecan—Infection—Methotrexate—psoriatic arthritis	0.00017	0.000909	CcSEcCtD
Irinotecan—Feeling abnormal—Prednisone—psoriatic arthritis	0.000168	0.000902	CcSEcCtD
Irinotecan—Asthenia—Dexamethasone—psoriatic arthritis	0.000168	0.000902	CcSEcCtD
Irinotecan—Asthenia—Betamethasone—psoriatic arthritis	0.000168	0.000902	CcSEcCtD
Irinotecan—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000168	0.000897	CcSEcCtD
Irinotecan—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000167	0.000896	CcSEcCtD
Irinotecan—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000167	0.000895	CcSEcCtD
Irinotecan—Nausea—Prednisolone—psoriatic arthritis	0.000167	0.000895	CcSEcCtD
Irinotecan—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000165	0.000884	CcSEcCtD
Irinotecan—Vomiting—Triamcinolone—psoriatic arthritis	0.000164	0.000881	CcSEcCtD
Irinotecan—Vomiting—Methylprednisolone—psoriatic arthritis	0.000164	0.000879	CcSEcCtD
Irinotecan—Rash—Triamcinolone—psoriatic arthritis	0.000163	0.000873	CcSEcCtD
Irinotecan—Dermatitis—Triamcinolone—psoriatic arthritis	0.000163	0.000873	CcSEcCtD
Irinotecan—Anorexia—Methotrexate—psoriatic arthritis	0.000163	0.000872	CcSEcCtD
Irinotecan—Rash—Methylprednisolone—psoriatic arthritis	0.000163	0.000871	CcSEcCtD
Irinotecan—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000163	0.000871	CcSEcCtD
Irinotecan—Headache—Triamcinolone—psoriatic arthritis	0.000162	0.000868	CcSEcCtD
Irinotecan—Headache—Methylprednisolone—psoriatic arthritis	0.000162	0.000866	CcSEcCtD
Irinotecan—Abdominal pain—Prednisone—psoriatic arthritis	0.000162	0.000865	CcSEcCtD
Irinotecan—Body temperature increased—Prednisone—psoriatic arthritis	0.000162	0.000865	CcSEcCtD
Irinotecan—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000161	0.00086	CcSEcCtD
Irinotecan—Diarrhoea—Betamethasone—psoriatic arthritis	0.000161	0.00086	CcSEcCtD
Irinotecan—Hypotension—Methotrexate—psoriatic arthritis	0.00016	0.000855	CcSEcCtD
Irinotecan—Dizziness—Dexamethasone—psoriatic arthritis	0.000155	0.000831	CcSEcCtD
Irinotecan—Dizziness—Betamethasone—psoriatic arthritis	0.000155	0.000831	CcSEcCtD
Irinotecan—Insomnia—Methotrexate—psoriatic arthritis	0.000155	0.000827	CcSEcCtD
Irinotecan—Nausea—Triamcinolone—psoriatic arthritis	0.000154	0.000823	CcSEcCtD
Irinotecan—Paraesthesia—Methotrexate—psoriatic arthritis	0.000153	0.000821	CcSEcCtD
Irinotecan—Nausea—Methylprednisolone—psoriatic arthritis	0.000153	0.000821	CcSEcCtD
Irinotecan—Dyspnoea—Methotrexate—psoriatic arthritis	0.000152	0.000816	CcSEcCtD
Irinotecan—Somnolence—Methotrexate—psoriatic arthritis	0.000152	0.000813	CcSEcCtD
Irinotecan—Hypersensitivity—Prednisone—psoriatic arthritis	0.000151	0.000806	CcSEcCtD
Irinotecan—Dyspepsia—Methotrexate—psoriatic arthritis	0.00015	0.000805	CcSEcCtD
Irinotecan—Vomiting—Dexamethasone—psoriatic arthritis	0.000149	0.000799	CcSEcCtD
Irinotecan—Vomiting—Betamethasone—psoriatic arthritis	0.000149	0.000799	CcSEcCtD
Irinotecan—Decreased appetite—Methotrexate—psoriatic arthritis	0.000149	0.000795	CcSEcCtD
Irinotecan—Rash—Dexamethasone—psoriatic arthritis	0.000148	0.000792	CcSEcCtD
Irinotecan—Rash—Betamethasone—psoriatic arthritis	0.000148	0.000792	CcSEcCtD
Irinotecan—Dermatitis—Dexamethasone—psoriatic arthritis	0.000148	0.000792	CcSEcCtD
Irinotecan—Dermatitis—Betamethasone—psoriatic arthritis	0.000148	0.000792	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000148	0.00079	CcSEcCtD
Irinotecan—Fatigue—Methotrexate—psoriatic arthritis	0.000147	0.000789	CcSEcCtD
Irinotecan—Headache—Dexamethasone—psoriatic arthritis	0.000147	0.000787	CcSEcCtD
Irinotecan—Headache—Betamethasone—psoriatic arthritis	0.000147	0.000787	CcSEcCtD
Irinotecan—Asthenia—Prednisone—psoriatic arthritis	0.000147	0.000785	CcSEcCtD
Irinotecan—Pain—Methotrexate—psoriatic arthritis	0.000146	0.000782	CcSEcCtD
Irinotecan—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000141	0.000754	CcSEcCtD
Irinotecan—Diarrhoea—Prednisone—psoriatic arthritis	0.00014	0.000749	CcSEcCtD
Irinotecan—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00014	0.000748	CcSEcCtD
Irinotecan—Nausea—Dexamethasone—psoriatic arthritis	0.000139	0.000747	CcSEcCtD
Irinotecan—Nausea—Betamethasone—psoriatic arthritis	0.000139	0.000747	CcSEcCtD
Irinotecan—Dizziness—Prednisone—psoriatic arthritis	0.000135	0.000724	CcSEcCtD
Irinotecan—Abdominal pain—Methotrexate—psoriatic arthritis	0.000135	0.000723	CcSEcCtD
Irinotecan—Body temperature increased—Methotrexate—psoriatic arthritis	0.000135	0.000723	CcSEcCtD
Irinotecan—Vomiting—Prednisone—psoriatic arthritis	0.00013	0.000696	CcSEcCtD
Irinotecan—Rash—Prednisone—psoriatic arthritis	0.000129	0.00069	CcSEcCtD
Irinotecan—Dermatitis—Prednisone—psoriatic arthritis	0.000129	0.000689	CcSEcCtD
Irinotecan—Headache—Prednisone—psoriatic arthritis	0.000128	0.000686	CcSEcCtD
Irinotecan—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000126	0.000674	CcSEcCtD
Irinotecan—Asthenia—Methotrexate—psoriatic arthritis	0.000123	0.000656	CcSEcCtD
Irinotecan—Nausea—Prednisone—psoriatic arthritis	0.000121	0.00065	CcSEcCtD
Irinotecan—Diarrhoea—Methotrexate—psoriatic arthritis	0.000117	0.000626	CcSEcCtD
Irinotecan—Dizziness—Methotrexate—psoriatic arthritis	0.000113	0.000605	CcSEcCtD
Irinotecan—Vomiting—Methotrexate—psoriatic arthritis	0.000109	0.000582	CcSEcCtD
Irinotecan—Rash—Methotrexate—psoriatic arthritis	0.000108	0.000577	CcSEcCtD
Irinotecan—Dermatitis—Methotrexate—psoriatic arthritis	0.000108	0.000576	CcSEcCtD
Irinotecan—Headache—Methotrexate—psoriatic arthritis	0.000107	0.000573	CcSEcCtD
Irinotecan—Nausea—Methotrexate—psoriatic arthritis	0.000101	0.000543	CcSEcCtD
